GlassScriptPhysician profile
Kenneth A Warm
NPI 1982783379
$1,006.97
in general payments reported to CMS, 2019-2025
22 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $107 · 2021: $104 · 2022: $22.92 · 2023: $74.82 · 2024: $113 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $146.22 | 2019-2022 | |
| Eisai INC. | $107.11 | 2023-2025 | |
| Allergan, INC. | $105.90 | 2019-2020 | |
| Lilly USA, LLC | $69.46 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Abbvie INC. | $69.36 | 2021-2025 | |
| Glaxosmithkline, LLC. | $67.01 | 2021-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Gilead Sciences, INC. | $59.89 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $59.35 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $50.81 | 2019 | |
| Astellas Pharma US INC | $27.22 | 2024 | Veozah |
| Novo Nordisk INC | $26.92 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.05 | 2019 | |
| Fidia Pharma USA INC. | $23.90 | 2019 | |
| Teleflex LLC | $23.89 | 2025 | Urolift |
| Organon LLC | $23.59 | 2025 | Nexplanon |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.36 | 2021 | |
| Janssen Pharmaceuticals, INC | $23.12 | 2021 | |
| Sanofi Pasteur INC. | $21.01 | 2025 | |
| Merck Sharp & Dohme LLC | $18.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.36 | 2019 | |
| Boston Scientific Corporation | $11.81 | 2019 | |
| Cranial Technologies, INC | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Warm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.